ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical gross margin
Gross margin is gross profit as a percentage of revenue.
ENvue Medical's gross margin for the twelve months ending Jun 30, 2026 was -26.1%. For fiscal 2025 it was 6.0%, against 59.0% the year before. The highest annual figure on record is 67.3% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.0% | −53.0 |
| FY2024 | Dec 31, 2024 | 59.0% | −8.4 |
| FY2023 | Dec 31, 2023 | 67.3% | +45.1 |
| FY2022 | Dec 31, 2022 | 22.2% | −23.2 |
| FY2021 | Dec 31, 2021 | 45.4% | +11.1 |
| FY2020 | Dec 31, 2020 | 34.3% | −18.7 |
| FY2019 | Dec 31, 2019 | 53.0% | +2.7 |
| FY2018 | Dec 31, 2018 | 50.3% | −12.9 |
| FY2017 | Dec 31, 2017 | 63.2% | +1.6 |
| FY2016 | Dec 31, 2016 | 61.6% | −5.1 |
| FY2015 | Dec 31, 2015 | 66.7% | +12.5 |
| FY2014 | Dec 31, 2014 | 54.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -111.3% | −104.2 |
| Q1 FY2026 | Mar 31, 2026 | -8.4% | −44.4 |
| Q4 FY2025 | Dec 31, 2025 | -118.6% | −182.3 |
| Q3 FY2025 | Sep 30, 2025 | 26.2% | −9.2 |
| Q2 FY2025 | Jun 30, 2025 | -7.1% | −59.5 |
| Q1 FY2025 | Mar 31, 2025 | 36.0% | −36.1 |
| Q4 FY2024 | Dec 31, 2024 | 63.7% | +1.1 |
| Q3 FY2024 | Sep 30, 2024 | 35.4% | −40.8 |
| Q2 FY2024 | Jun 30, 2024 | 52.4% | −21.1 |
| Q1 FY2024 | Mar 31, 2024 | 72.1% | +5.7 |
| Q4 FY2023 | Dec 31, 2023 | 62.6% | −19.9 |
| Q3 FY2023 | Sep 30, 2023 | 76.2% | +18.3 |
| Q2 FY2023 | Jun 30, 2023 | 73.5% | +34.5 |
| Q1 FY2023 | Mar 31, 2023 | 66.4% | +33.2 |
| Q3 FY2022 | Sep 30, 2022 | 82.5% | +36.8 |
| Q2 FY2022 | Jun 30, 2022 | 57.9% | −7.5 |
| Q1 FY2022 | Mar 31, 2022 | 39.0% | −35.8 |
| Q4 FY2021 | Dec 31, 2021 | 33.2% | +4.3 |
| Q3 FY2021 | Sep 30, 2021 | 45.7% | −20.3 |
| Q2 FY2021 | Jun 30, 2021 | 65.4% | +51.3 |
| Q1 FY2021 | Mar 31, 2021 | 74.8% | +30.0 |
| Q4 FY2020 | Dec 31, 2020 | 28.9% | +58.8 |
| Q3 FY2020 | Sep 30, 2020 | 66.0% | +19.5 |
| Q2 FY2020 | Jun 30, 2020 | 14.1% | −64.6 |
| Q1 FY2020 | Mar 31, 2020 | 44.7% | −22.4 |
| Q4 FY2019 | Dec 31, 2019 | -29.9% | −65.1 |
| Q3 FY2019 | Sep 30, 2019 | 46.5% | +31.7 |
| Q2 FY2019 | Jun 30, 2019 | 78.7% | +20.4 |
| Q1 FY2019 | Mar 31, 2019 | 67.1% | −4.3 |
| Q4 FY2018 | Dec 31, 2018 | 35.2% | −19.1 |
| Q3 FY2018 | Sep 30, 2018 | 14.8% | −51.3 |
| Q2 FY2018 | Jun 30, 2018 | 58.3% | −7.1 |
| Q1 FY2018 | Mar 31, 2018 | 71.4% | +2.2 |
| Q4 FY2017 | Dec 31, 2017 | 54.3% | −10.2 |
| Q3 FY2017 | Sep 30, 2017 | 66.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 65.4% | – |
| Q1 FY2017 | Mar 31, 2017 | 69.2% | – |
| Q2 FY2016 | Jun 30, 2016 | 64.5% | – |
See a number that looks wrong?